Ex parte CHAUG et al. - Page 8




          Appeal No. 1999-1539                                                        
          Application 08/584,118                                                      


               In our analysis, we are guided by the general proposition              
          that in an appeal involving a rejection under 35 U.S.C. § 103,              
          an examiner is under a burden to make out a prima facie case                
          of obviousness.  If that burden is met, the burden of going                 
          forward then shifts to the applicant to overcome the prima                  
          facie case with argument and/or evidence.  Obviousness is then              
          determined                                                                  
          on the basis of the evidence as a whole and the relative                    
          persuasiveness of the arguments.  See In re Oetiker, 977 F.2d               
          1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In re                    
          Hedges, 783 F.2d 1038, 1039, 228 USPQ 685, 686 (Fed. Cir.                   
          1986); In re Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788               
          (Fed. Cir. 1984); and In re Rinehart, 531 F.2d 1048, 1052, 189              
          USPQ 143, 147 (CCPA 1976).  We are further guided by the                    
          precedent of our reviewing court that the limitations from the              
          disclosure are not to be imported into the claims.  In re                   
          Lundberg, 244 F.2d 543, 113 USPQ 530 (CCPA 1957); In re                     
          Queener, 796 F.2d 461, 230 USPQ 438 (Fed. Cir. 1986).  We also              
          note that the arguments not made separately for any individual              
          claim or claims are considered waived.  See 37 CFR § 1.192(a)               
          and (c).  In re Baxter Travenol Labs., 952 F.2d 388, 391, 21                
                                          8                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007